The EPO Guidelines 2024 G.II.6.1.3 explicitly allow an antibody to be claimed by reference to its epitope, i.e. the structurally defined part of the antigen that it specifically binds to. However, decision T2552/22 issued by Board 3.3.04 highlights the importance...
Read more